Gaekwad Medical Associates Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.37 M
- Company Age 34 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.20 M
- Revenue Growth -20.97%
- Profit Growth 81.82%
- Ebitda 195.15%
- Net Worth 56.17%
- Total Assets -1.68%
About Gaekwad Medical Associates
Gaekwad Medical Associates Private Limited (GMAPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 July 1990 and has a history of 34 years and seven months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.37 M.
The company currently has active open charges totaling ₹8.20 M.
Naresh Gaekwad and Madan Shivajirao serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110KA1990PTC011040
- Company No.
011040
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jul 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Gaekwad Medical Associates?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Gaekwad  | Director | 05-Jul-1990 | Current |
| Madan Shivajirao | Director | 05-Jul-1990 | Current |
Financial Performance of Gaekwad Medical Associates.
Gaekwad Medical Associates Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 20.97% decrease. The company also saw a substantial improvement in profitability, with a 81.82% increase in profit. The company's net worth Soared by an impressive increase of 56.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gaekwad Medical Associates?
In 2021, Gaekwad Medical Associates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹8.20 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Mysore : 0.77 Cr
- Corporation Bank : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Mar 2007 | State Bank Of Mysore | ₹5.00 M | Open |
| 02 Mar 2007 | State Bank Of Mysore | ₹2.70 M | Open |
| 07 Nov 2006 | Corporation Bank | ₹0.50 M | Open |
How Many Employees Work at Gaekwad Medical Associates?
Unlock and access historical data on people associated with Gaekwad Medical Associates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gaekwad Medical Associates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gaekwad Medical Associates's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
